During the past decade, Instituto Médico Especializado (IME) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Médico Especializado (IME)" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Médico Especializado (IME)" are "Obesity" (3 trials), "Overweight" (2 trials), "Alzheimer's Disease" (1 trials), "Diabetes" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Instituto Médico Especializado (IME)" in a lesser frequency.

Most popular intervention types in "Instituto Médico Especializado (IME)" are "Drug" (11 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Tirzepatide" (4 trials), "BI 685509" (1 trials), "Fenebrutinib" (1 trials) and "Fesoterodine 4mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Médico Especializado (IME)" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Médico Especializado (IME)". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto Médico Especializado (IME), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Médico Especializado (IME), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".